1. Ermol'eva 3. V. Antibiotiki, interferon, bakterial'nye polisakharidy .- M.: Meditsina, 1968.- S. 384.
2. Ulanova M. A., Padyukov L. I., Tatochenko V. K. i dr. Osobennosti gumoral'nogo immunnogo otveta na Str. pneumonium u detei: opredelenie antitel v syvorotke krovi, plevral'noi zhidkosti, slyune / / Zhuri, mikrobiol.- 1990.- № 2.- S. 55- 62.
3. Cimadamore M., Agriesti G., Testa A. Evaluation of salivary IgA titre in children sutterin g from reccurent respiratory infections treatm with poliwalent oral vaccines / / Minerva pediat.- 1988.- Vol. 40, N 6.- P. 355-360.
4. Clot I., Angari M. Immunostim ulation induite par un lusat bacterien luophilise Etude in vitro des reponses specifigues et non specifigues / / Med. et Hyg.- 1980.- Vol. 38.- P. 2776- 2782.
5. De Mattia D., Mantagna O., Abtoniora M. Induction of serum IgA development in cattarhal childrene using a poluvalent oral bacterial vaccine / / Minerva pediat.- 1978.- Vol. 30, N 6.- P. 469- 476.
6. Gunter C., Lieben S., Wess A. et al. Sekretorische Anticorper werden nicht durch orale Immunisierung mit bacteriellen Ribosomen stimuliert / / Gesellschaft fur paediatrische Pneumologie: Jahrestagung. Dresden 1991.- N 102.
7. Kaperellova A., Sulko M., Krouinova A. et al. Immunologie indicators in the treatment of reccurent respiratory diseases using peroral bacterial vaccines / / Gesch. Pediat.- 1989.- Bd 44, N 8.- S. 454- 458.
8. Maestroni G. I., Losa G. A. Clinical and immunobiological effect of an orraly administered bacterial extract / / Int. J. Immunopharmacol.- 1984.- Vol. 6.- P. 111 - 117.
9. Milano C., Di Fazio A., Bellioni P. et al. C ontroled trial of a polluvallent antibacterial vaccine in children viht recourent respiratory infections / / Minerva pediat.- 1980.- Vol. 32, N 9.- P. 641- 646.
10. Oggiano N., Di Giralamo F., Salvu c ci C. et al. Polyvalent oral bacterial vaccine in recourent respiratory infections / / Ibid.- 1985.- Vol. 37, N 19.- P. 741- 745.
11. Palma-Carlos A. G., Palm a-Carlos M. L. Immunomodulation with Bacterial Extracts in Respiratory Diseases / / Lung.- 1990.- Vol. 168.- P. 732- 736.
12. Puigdollers I. M ., Podes Serna G., Hernandezdalrey I. et al. Immunoglobulin production in m an stimullated bi ab orally administered bacterial lysate / / Respiration.- 1980.- Vol. 40.- P. 142- 149.
13. Putto A., Ruuskanen O., Meurman O. et al. Valne of C-reactive protein in the management of febrile children-././ Arch. Dis. Child.- 1986.- Vol. 61.- P. 24- 29.
14. Scotti L., Biondelli G., Borzanni M. The use of a polyvalent oral bacterial vaccine for reccurent respiratory infections in children / / Minerva pediat.- 1987.- Vol. 35; N 7 - P. 251-256.
15. Schaad U. B., Fazine /. C., Fust T. Prospektive placebocontrolirte Doppelblindstudie mit einem Bakterienlysat bei Infektionen der Atemwege und des OR L-Bereichesim Kindersalter / / Helv. paediat. Acta.- 1986.- Vol. 41 N 1/2.- P. 7- 17.
16. Wybran I., Libin M. et al. Activation of natural killer cells and cytokine production in Humans by Bacterial Extracts [OM - 85 BV] / / Lung.- 1990.- Vol. 168 - P. 720- 725.